These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7368788)

  • 1. [Undesirable side effects of drugs in medical practice. What are the principal dangers?].
    Kimbel KH
    ZFA (Stuttgart); 1980 Jan; 56(2):71-6. PubMed ID: 7368788
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of the drugs in man for the first time. The inescapable conditions and the problems].
    Kleinsorge H
    Med Klin; 1976 Jun; 71(26):1093-1108. PubMed ID: 934005
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)].
    Schnieders B
    Arzneimittelforschung; 1976; 26(1A):158-63. PubMed ID: 947195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Information on drugs and the risk of drugs. Staged project for the coordination of measures].
    Kimbel KH
    Med Klin; 1976 Feb; 71(9):390. PubMed ID: 1256339
    [No Abstract]   [Full Text] [Related]  

  • 5. [Registration, collection, and evaluation of drug side effects. Subsequent control necessary for drug security].
    Stockhausen J
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):460-3. PubMed ID: 5046056
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of drug side-effects in a Medical University Hospital].
    Weber E; Gundert-Remy U; Hahn KJ; Schaumann E; Walter E; Nebel G; Didier W; Deynet G
    Verh Dtsch Ges Inn Med; 1972; 78():1574-7. PubMed ID: 4665612
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liability of the physician in prescribing new drugs].
    Trube-Becker E
    Med Klin; 1967 Jan; 62(4):156-7. PubMed ID: 5588024
    [No Abstract]   [Full Text] [Related]  

  • 8. [Compulsory health education when using new drugs].
    Oelkers H
    Med Klin; 1971 Aug; 66(35):1173-8. PubMed ID: 5570841
    [No Abstract]   [Full Text] [Related]  

  • 9. [Medical questions with respect to the introduction of new drug specialties into the German Federal Republic].
    Grillmaier JB
    Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):315-31. PubMed ID: 5365590
    [No Abstract]   [Full Text] [Related]  

  • 10. [Is drug therapy safer as a result of the drug legislation?].
    Kimbel KH
    Internist (Berl); 1980 Jun; 21(6):306-10. PubMed ID: 7005166
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug effectiveness in the framework of drug legislation and health insurance law].
    Töns H
    Internist (Berl); 1980 Jun; 21(6):339-45. PubMed ID: 7005171
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of the West German drug law upon development of clinical pharmacology.
    Kampffmeyer H
    Clin Pharmacol Ther; 1974 Sep; 16(3):616-9. PubMed ID: 4413783
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drugs in animal feed].
    Kaemmerer K
    Zentralbl Veterinarmed B; 1970 Jan; 17(1):91-102. PubMed ID: 5422242
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug safety].
    Herken H
    Med Klin; 1974 Apr; 69(16):659-66. PubMed ID: 4600058
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the therapeutical range of drugs].
    Herken H
    Internist (Berl); 1974 Jan; 15(1):1-6. PubMed ID: 4591161
    [No Abstract]   [Full Text] [Related]  

  • 16. [The doctor's responsibility and risk in the prescribing of drugs].
    Aschenbrenner R
    Munch Med Wochenschr; 1973 Apr; 115(17):741-6. PubMed ID: 4574431
    [No Abstract]   [Full Text] [Related]  

  • 17. [New order in drug legislation].
    Feiden K
    Dtsch Med Wochenschr; 1975 Apr; 100(17):972-6. PubMed ID: 1091438
    [No Abstract]   [Full Text] [Related]  

  • 18. [Crucial points of the future drug law in the Federal Republic of Germany].
    Hasskarl H
    Med Klin; 1975 Apr; 70(14):633-6. PubMed ID: 1152798
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possibilities and limits of drug supervision].
    Homann G
    Med Klin; 1970 Aug; 65(35):1518-20. PubMed ID: 5516116
    [No Abstract]   [Full Text] [Related]  

  • 20. [Letter: Determination of adverse effects of drugs].
    Brück D
    Med Klin; 1974 Nov; 69(48):2007. PubMed ID: 4453296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.